Related Experiment Videos
Comparative study of the p53-mdm2 and p53-MDMX interfaces
V Böttger1, A Böttger, C Garcia-Echeverria
1Cancer Research Campaign Laboratories, University of Dundee, Scotland, UK.
Abstract:
Mdm2 and MDMX are two structurally related p53-binding proteins which show the highest level of sequence similarity in the N-terminal p53-binding domains. Apart from its ability to inhibit p53 mediated transcription, a feature it shares with mdm2, very little is known about the physiological functions of MDMX. It is clearly distinct from mdm2 since its expression appears not to be regulated by p53 and it cannot compensate for lack of mdm2 in early development. We present data on the structural similarity between the p53 binding pockets of mdm2 and MDMX using p53- and phage-selected peptides. From the results we conclude that our recently devised innovative approach to reverse the mdm2-mediated inhibition of p53's transactivation function in vivo would probably target MDMX as well. Strategies for selectively targeting mdm2 and MDMX are suggested and a possible mechanism for regulating the p53-mdm2/MDMX interactions by protein phosphorylation is discussed.
Insights
Mdm2 and MDMX proteins bind to p53 and regulate its function. This study reveals structural similarities between Mdm2 and MDMX, suggesting a new therapeutic strategy targeting both proteins to restore p53 activity.
Area of Science:
- Molecular Biology
- Cancer Research
- Protein Interactions
Background:
- Mdm2 and MDMX are structurally similar proteins that bind to and inhibit the tumor suppressor p53.
- While Mdm2's functions are well-studied, MDMX's physiological roles remain largely unknown.
- MDMX differs from Mdm2 as its expression is not regulated by p53 and it cannot compensate for Mdm2 deficiency.
Purpose of the Study:
- To investigate the structural similarities between the p53-binding domains of Mdm2 and MDMX.
- To explore the potential of targeting both Mdm2 and MDMX with a unified therapeutic strategy.
- To discuss mechanisms regulating p53-Mdm2/MDMX interactions.
Main Methods:
- Comparative structural analysis of Mdm2 and MDMX p53-binding pockets.
- Utilizing p53- and phage-selected peptides to probe protein interactions.
- In vivo studies to assess the impact of targeting Mdm2/MDMX on p53 transactivation.
Main Results:
- Significant structural similarity was identified between the p53-binding pockets of Mdm2 and MDMX.
- An innovative approach to reverse Mdm2-mediated p53 inhibition showed potential efficacy against MDMX as well.
- Distinct strategies for selectively targeting Mdm2 and MDMX were proposed.
Conclusions:
- The structural similarity between Mdm2 and MDMX suggests a shared therapeutic vulnerability.
- The developed strategy for reversing Mdm2 inhibition may also be effective for MDMX.
- Protein phosphorylation is a potential mechanism for regulating p53-Mdm2/MDMX interactions.